Related Experiment Video
Updated: Sep 28, 2025

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Tumor-derived exosomes in hypoxic microenvironment: release mechanism, biological function and clinical application
Da Qian1, Yaoyao Xie2, Mingyao Huang3
1Department of Burn and Plastic Surgery-Hand Surgery, First People's Hospital of Changshu City, Changshu Hospital Affiliated to Soochow University, Soochow, China.
Hypoxia (low oxygen) in tumors increases exosome secretion, promoting cancer progression and immune evasion. Targeting these hypoxia-induced exosomes offers a promising cancer therapy strategy.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Hypoxia is a hallmark of solid tumors, correlating with increased aggressiveness and poor patient outcomes.
- Intercellular communication within the tumor microenvironment is crucial for cancer progression.
- Exosomes, nano-scale vesicles, mediate this communication, carrying molecular cargo from source cells.
Purpose of the Study:
- To review the mechanisms by which hypoxia regulates exosome secretion.
- To discuss the role of exosomes derived from hypoxic tumor cells in cancer progression and immune escape.
- To explore therapeutic strategies targeting hypoxia-induced exosomes.
Main Methods:
- Literature review of recent studies on hypoxia and exosome biology in cancer.
- Analysis of physiological mechanisms linking hypoxia to exosome secretion and function.
- Synthesis of current research on the impact of hypoxic exosomes on cancer progression and immunity.
Main Results:
- Hypoxic conditions stimulate increased exosome production by cancer cells.
- Hypoxic exosomes contribute to tumor progression, including angiogenesis and metastasis.
- Exosomes secreted under hypoxia play a role in immune suppression and evasion of anti-tumor responses.
Conclusions:
- Hypoxia significantly influences exosome secretion and function in cancer.
- Hypoxic exosomes are key mediators of tumor progression and immune escape.
- Targeting hypoxia-induced exosomes presents a potential novel therapeutic avenue for cancer treatment.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
The Tumor Microenvironment
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

